Richard M Hindley

This inventor holds 26 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Beecham Group Plc, Smithkline Beecham Corporation. Active years: 1978-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard M Hindley. Retrieved from https://idiyas.com/inventor/richard-m-hindley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 96.2

Average Co-Inventor Count = 1.5

ph-index = 11

Forward Citations = 393(Granted Patents)

Location History:

Reigate, EN (1978)
Reigate, GB (1979 - 1989)
Surrey, GB (1991)
Epsom, GB (1990 - 2004)

Company Filing History:

Smithkline Beecham Corporation

patents

Years Active: 1978-2004

Loading Chart...

Areas of Expertise:

Thiazolidinedione Derivatives

Dioxothiazolidine Compounds

Oxazolidine Dione Derivatives

Novel Compounds

Tertiary Amines

2-Phenylethylamine Derivatives

Secondary Amines

Hypolipidaemic Compounds

Pharmaceutical Activity

Compounds for Eating Disorders

Atherosclerosis Treatment

Hypolipidaemic Compositions

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6686475 - Compounds (2004-02-03),

2. 6288095 - Compounds (2001-09-11),

3. 5756525 - Compounds for treating eating disorders (1998-05-26),

4. 5726055 - Process for the preparation of pharmaceutically active thiazolidine (1998-03-10),

5. 5646169 - Compounds for treating eating disorders in which blood glucose levels (1997-07-08),

6. 5521201 - Method for treatment of atherosclerosis (1996-05-28),

7. 5478851 - Dioxothiazolidine compounds (1995-12-26),

8. 5478850 - Thiazolidinedione derivatives (1995-12-26),

9. 5391565 - Oxazolidine dione derivatives (1995-02-21),

10. 5260445 - 2,4-thiazolidinediones (1993-11-09),

11. 5232925 - Compounds (1993-08-03),

12. 5194443 - Compounds (1993-03-16),

13. 5075300 - Novel compounds (1991-12-24),

14. 5063240 - Novel compounds (1991-11-05),

15. 5002953 - Novel compounds (1991-03-26),

Title: Richard M. Hindley: Innovator in Cardiovascular and Eating Disorder Treatments

Introduction

Richard M. Hindley, based in Epsom, GB, is a prolific inventor with an impressive portfolio consisting of 26 patents. His work primarily focuses on advancements in the treatment and prophylaxis of cardiovascular diseases and eating disorders. Hindley's innovative contributions have significantly impacted the pharmaceutical landscape.

Latest Patents

Among his noteworthy patents, one of the latest is centered on a method for treating cardiovascular diseases or eating disorders in mammals. This patent details the administration of an effective, non-toxic amount of a compound of a specific formula to individuals in need, showcasing Hindley’s commitment to developing effective therapeutic solutions.

Career Highlights

Throughout his career, Richard has collaborated with major companies such as Beecham Group Plc, a significant player in the pharmaceutical sector. His work at Beecham highlighted his ability to combine scientific knowledge with practical applications, pushing forward the boundaries of medical treatments.

Collaborations

Hindley has collaborated with notable professionals in the field, including Michael Antony Cawthorne and Keith H. Baggaley. These partnerships have facilitated the exchange of ideas and innovations, fostering advancements in their respective research areas.

Conclusion

Richard M. Hindley's contributions to the fields of cardiovascular and eating disorder treatments through his patents reflect his dedication to enhancing healthcare. His extensive background and collaboration with other experts continue to inspire innovations that may lead to breakthroughs in medical science.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]